The University of Southampton
University of Southampton Institutional Repository

Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update

Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update
Importance: distressing sexual problems are a common complaint of menopausal women. In 2013, a Cochrane review assessed the effect of hormone therapy on sexual function in menopausal women; however, new evidence has since been published which should be considered.

Objective: this systematic review and meta-analysis aims to update the evidence synthesis on the effect of hormone therapy, compared to control, on sexual function in perimenopausal and postmenopausal women.

Evidence Review: thirteen databases and clinical trial registries (Cochrane Central Register of Controlled Trials, EMBASE, Medical Literature Analysis and Retrieval System Online, PsycINFO, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Literatura Latino-Americana e do Caribe em Ciéncias da Saúde, Database of Abstracts of Reviews of Effects, ClinicalTrials.gov, International Clinical Trials Registry Platform, Iranian Registry of Clinical Trials, Chinese Clinical Trial Registry, ISRCTN) were searched from December, 2012 until March 30, 2022. Backward reference searching on all retrieved full texts was also performed. Study quality was assessed using the Cochrane ROB.2 tool. Data was pooled in random effect model meta-analyses which included all studies identified in the present search as well as all studies previously included in the 2013 Cochrane review.

Findings: forty-seven randomized controlled trials (35,912 participants) were included in the systematic review, and 34 randomized controlled trials (15,079 participants) were included in the meta-analysis. The meta-analysis revealed that in comparison to control estrogen therapy (SMD=0.16, 95%CI, 0.02 to 0.29, I2=59%, 2925 participants, 16 studies), estrogen plus progestogen therapy (SMD= 0.11, 95%CI, -0.07 to 0.29, I2=65%, 2432 participants, 7 studies), tibolone (SMD=0.15, 95%CI, 0.02 to 0.28, I2=0%, 916 participants, 2 studies), and selective estrogen receptor modulators (SMD=0.18, 95%CI, 0.06 to 0.30, I2=0%, 1058 participants, 4 studies) may result in no effect to small benefit on sexual function composite score.
Conclusion and Relevance
Hormone therapy may slightly improve sexual functioning. This potential small benefit should be considered when discussing treatment options for other menopausal symptoms.
1072-3714
Meziou, Nadia
780def6a-b50d-438d-9be0-b22597dcbed4
Scholfield, Clare
be4d126a-3da1-444d-b562-c1fe05b6fdfd
Taylor, Caroline A.
37d3270e-3bab-4bf0-902f-b913111c8a45
Armstrong, Heather
3dc9c223-1a61-47ad-ab0b-50d06cddf4f2
Meziou, Nadia
780def6a-b50d-438d-9be0-b22597dcbed4
Scholfield, Clare
be4d126a-3da1-444d-b562-c1fe05b6fdfd
Taylor, Caroline A.
37d3270e-3bab-4bf0-902f-b913111c8a45
Armstrong, Heather
3dc9c223-1a61-47ad-ab0b-50d06cddf4f2

Meziou, Nadia, Scholfield, Clare, Taylor, Caroline A. and Armstrong, Heather (2023) Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update. Menopause, 30 (6). (doi:10.1002/14651858.CD009672.pub2).

Record type: Article

Abstract

Importance: distressing sexual problems are a common complaint of menopausal women. In 2013, a Cochrane review assessed the effect of hormone therapy on sexual function in menopausal women; however, new evidence has since been published which should be considered.

Objective: this systematic review and meta-analysis aims to update the evidence synthesis on the effect of hormone therapy, compared to control, on sexual function in perimenopausal and postmenopausal women.

Evidence Review: thirteen databases and clinical trial registries (Cochrane Central Register of Controlled Trials, EMBASE, Medical Literature Analysis and Retrieval System Online, PsycINFO, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Literatura Latino-Americana e do Caribe em Ciéncias da Saúde, Database of Abstracts of Reviews of Effects, ClinicalTrials.gov, International Clinical Trials Registry Platform, Iranian Registry of Clinical Trials, Chinese Clinical Trial Registry, ISRCTN) were searched from December, 2012 until March 30, 2022. Backward reference searching on all retrieved full texts was also performed. Study quality was assessed using the Cochrane ROB.2 tool. Data was pooled in random effect model meta-analyses which included all studies identified in the present search as well as all studies previously included in the 2013 Cochrane review.

Findings: forty-seven randomized controlled trials (35,912 participants) were included in the systematic review, and 34 randomized controlled trials (15,079 participants) were included in the meta-analysis. The meta-analysis revealed that in comparison to control estrogen therapy (SMD=0.16, 95%CI, 0.02 to 0.29, I2=59%, 2925 participants, 16 studies), estrogen plus progestogen therapy (SMD= 0.11, 95%CI, -0.07 to 0.29, I2=65%, 2432 participants, 7 studies), tibolone (SMD=0.15, 95%CI, 0.02 to 0.28, I2=0%, 916 participants, 2 studies), and selective estrogen receptor modulators (SMD=0.18, 95%CI, 0.06 to 0.30, I2=0%, 1058 participants, 4 studies) may result in no effect to small benefit on sexual function composite score.
Conclusion and Relevance
Hormone therapy may slightly improve sexual functioning. This potential small benefit should be considered when discussing treatment options for other menopausal symptoms.

Text
HT for sexual function (Feb 13, 2023) final accepted manuscript - Accepted Manuscript
Restricted to Repository staff only until 14 February 2024.
Available under License Creative Commons Attribution.
Request a copy
Text
Hormone_therapy_for_sexual_function_in.182 - Version of Record
Restricted to Repository staff only
Request a copy

More information

Accepted/In Press date: 14 February 2023
Published date: 10 May 2023

Identifiers

Local EPrints ID: 475973
URI: http://eprints.soton.ac.uk/id/eprint/475973
ISSN: 1072-3714
PURE UUID: 1fdbc805-39d1-467e-9775-2f804883c9c8
ORCID for Heather Armstrong: ORCID iD orcid.org/0000-0002-1071-8644

Catalogue record

Date deposited: 03 Apr 2023 16:38
Last modified: 12 May 2023 01:52

Export record

Altmetrics

Contributors

Author: Nadia Meziou
Author: Clare Scholfield
Author: Caroline A. Taylor

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×